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Hirschsprung disease, or congenital megacolon, is characterized by aganglionosis of the terminal bowel,
which leads to intestinal obstruction and chronic constipation. Several genes involved in the disease have
been identiﬁed. In particular, haploinsufﬁciency of SOX10, which encodes a transcription factor, results in
megacolon, often in combination with other disorders. Although Hirschsprung disease has been recognized
as a neurocristopathy, the cellular mechanisms that lead to aganglionosis in affected individuals are unclear.
Failure of mutant enteric progenitor cells to migrate into the gut, to survive, or to differentiate into appropriate
cell types at the appropriate time and in correct numbers might contribute to the disease phenotype. In the
present study, we use mice with a targeted deletion of Sox10 to study the etiology of Hirschsprung disease.
We demonstrate that neural crest-derived enteric progenitors that are heterozygous for the Sox10 mutation
colonize the proximal intestine and are unaffected in their survival capacity. However, unlike their wild-type
counterparts, mutant enteric neural crest-derived cells are unable to maintain their progenitor state and
acquire preneuronal traits, which results in a reduction of the progenitor pool size. Thus, the cells that normally
colonize the hindgut are depleted in the Sox10 mutant, causing the distal bowel to become aganglionic.
INTRODUCTION
Hirschsprung disease is a relatively common congenital disorder
that is defined by the absence of enteric ganglia in the myenteric
and submucosal plexuses along a variable length of the distal gut
(reviewed in 1). The abnormal innervation and absence of
peristaltic movement cause severe constipation, which results in
dilated megacolon. So far, the disorder can only be treated by
surgical resection of the affected bowel. The disease has a
prevalence of about 1 in 5000 infants with variable penetrance
that is, however, greater in males than in females. The
inheritance pattern is mostly complex, indicating the multi-
factorial nature of the disease. A recent genetic analysis of
Hirschsprung disease has revealed that a form of this disorder
can be explained by the interaction of three loci, one of which is
RET (2). Mutations in RET, which encodes a receptor tyrosine
kinase, are responsible for most cases of Hirschsprung disease
(reviewed in 3,4). Moreover, a few patients have been identified
with mutations in genes encoding glial cell line-derived
neurotrophic factor (GDNF) and neurturin (NTN), both of
which signal through RET (5–7). Deficiencies in signaling by
endothelin-3 (ET-3) and its receptor endothelin-B (ETB) have
also been implicated in congenital megacolon, both in mice and
in human patients (reviewed in 8). In addition to defects in
ligand–receptor pairs, mutations in two transcription factors have
been shown to result in aganglionosis of the terminal bowel in
human patients. SIP1 encodes a Smad interacting protein that
when mutated is responsible for a form of Hirschsprung disease
associated with mental retardation and microcephaly (9,10).
Finally, haploinsufficiency of SOX10, encoding a transcriptional
modulator with a Sry-type HMG domain, leads to Hirschsprung
disease (11,12). Frequently, affected patients also display
pigment anomalies and deafness, traits that are, in combination
with enteric aganglionosis, characteristic of the so-called
Waardenburg syndrome type 4 (WS4). Some patients with
SOX10 mutations moreover suffer from myelin deficiencies
beside the classical symptoms of WS4 (13–16).
The availability of mouse models has greatly facilitated the
analysis of the mechanisms causing Hirschsprung disease. Both
spontaneous mouse mutations and targeted deletion have
confirmed the importance of Hirschsprung disease genes in
the formation of the enteric nervous system (ENS) and helped
to identify Hirschsprung disease as a neurocristopathy
(reviewed in 1). In particular, dominant megacolon (DOM), a
spontaneous mutation of Sox10 (17,18), and a null mutation of
Sox10 generated by targeted deletion (19) lead to a phenotype
very similar to WS4 observed in human patients carrying
SOX10 mutations. Moreover, as in human patients, enteric
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aganglionosis and failures in pigmentation are caused by Sox10
haploinsufficiency and show variable penetrance, depending on
the genetic background (17–21). These features make Sox10
mouse mutants a valuable model system to study the etiology
of Hirschsprung disease. Homozygosity for a Sox10 mutation
leads to the absence of most neural crest derivatives
(17–19,22). This phenotype, together with the finding that
Sox10 is expressed in virtually all neural crest stem cells both
during migration and in postmigratory neural crest target
structures (23,24), indicated that Sox10 plays a role at earliest
stages of neural crest development. In agreement with this
hypothesis, analysis of the developmental potential of Sox10-
mutant neural crest cells revealed a dual requirement for Sox10
in regulating survival and fate decision processes (24).
Most of the ENS is generated by multipotent progenitor cells
derived from the vagal neural crest that enter the mesenchyme
of the foregut and then migrate in a proximal–distal direction to
eventually colonize the hindgut (1,25). Moreover, a minor
portion of the ENS is formed by cells derived from the sacral
neural crest. Thus, given the above-mentioned role of Sox10 in
neural crest cells, it is possible that cell death, aberrant fate
decisions and premature differentiation of neural crest cells
colonizing the intestine might lead to enteric aganglionosis in
individuals suffering from Hirschsprung disease. Alternatively,
deficient migration of enteric progenitor cells might prevent
their localization to the mutant hindgut, or progenitors able to
reach the distal gut might fail to undergo differentiation (8). In
the present study, we addressed these issues in mice
heterozygous for a targeted deletion of Sox10 (19).
RESULTS
Aganglionosis in the hindgut of Sox10
heterozygous mutant animals
The phenotypes of Sox10Dom mice appear to be identical to the
phenotypes observed in mice carrying a targeted Sox10 mutation
(Sox10lacZ mice) (19). In particular, similar to heterozygous
Sox10Dom mice (20,26,27), heterozygous Sox10lacZ mice
develop megacolon which causes death during the first postnatal
weeks in a significant fraction of the mutant animals (19).
In Sox10Dom mice, the development of megacolon is a
consequence of aganglionosis or hypoganglionosis that is
already established at embryonic stages (20,26). The penetrance
of this phenotype is modulated by the genetic background but
is highest in first-generation offspring from breedings of
Sox10Dom/þ males (on a mixed C57Bl/6J and C3HeB/FeJ
background) with C57Bl/6J females (20). To investigate
the enteric nervous system (ENS) of heterozygous Sox10lacZ
mutant embryos, we mated Sox10lacZ/þ males (that had been
back-crossed with C3HeB/FeJ mice for several generations (19))
with C57Bl/6J females. In situ hybridization experiments
revealed that the hindgut of heterozygous progeny of such
matings displayed an absence or reduced number of neuronal
cells marked by the receptor tyrosine kinase c-Ret (Fig. 1A and
B), neurofilament 160 (NF) (Fig. 1C and D) and peripherin (data
not shown). In contrast, the number of enteric ganglion cells
appeared to be comparable in more proximal parts of wild-type
and heterozygous mutant gut (Fig. 1A and B).
Reduction of progenitor cell numbers at
early stages of ENS development in
Sox10-heterozygous mutants
Sox10 is expressed in multipotent neural crest cells but is
downregulated as these cells adopt a neuronal fate (23,24).
Therefore, the loss of neuronal cells in the ENS of Sox10-
heterozygous mice is likely to be secondary to a defect in
multipotent neural crest-derived enteric progenitors. To address
this question, we investigated the expression of progenitor
markers in wild-type and mutant gut at early developmental
stages. Sox10 itself is a reliable marker for migratory and
postmigratory multipotent neural crest cells (24).
Semiquantitative RT–PCR analysis has previously indicated
that Sox10 mRNA levels are reduced by approximately half in
heterozygous as compared with wild-type embryos (19).
Nonetheless, Sox10 transcripts are readily detectable by
in situ hybridization experiments in migratory neural crest
cells and in progenitors present in peripheral ganglia and
nerves of Sox10lacZ/þ embryos (Fig. 2A and B) (17). Similarly,
the tyrosine kinase receptor ErbB3 is a marker for multipotent
neural crest cells and peripheral glia, which is expressed at
comparable levels in wild-type and Sox10-heterozygous mutant
Figure 1. Sox10lacZ/þ mice display aganglionosis in the hindgut. In situ hybri-
dization analysis on E17 cross-sections revealed that the gut of Sox10þ/þ
animals (þ/þ) is entirely innervated by neurons as assessed by c-Ret (A;
arrows) and neurofilament 160 (NF) (C; arrows) expression. In contrast, the
neuronal markers c-Ret (B; open arrows) and NF (D; open arrow) are absent
in the distal gut of a Sox10lacZ/þ animal (þ/), indicating that the mutant
animal lacks enteric neurons in the hindgut. More proximal parts of the gut
are normally innervated. Scale bars: 100mm.
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neural crest cells (24). In contrast to DRG, peripheral nerves
and other neural crest-derived structures, the hindgut was
devoid of Sox10- and ErbB3-expressing cells at E13 in five of
five Sox10-mutant embryos tested (open arrowhead in Fig. 2D;
and data not shown), in agreement with a previous study
performed with Sox10Dom/þ mice (27). At this stage, wild-type
hindgut has already been colonized by enteric progenitor cells
(arrowhead in Fig. 2C). Likewise, c-Ret expression was
detectable in the hindgut of wild-type but not of Sox10-
heterozygous mutant embryos at E13 (data not shown). Thus,
the impaired formation of an ENS in the distal gut of
Sox10-mutant animals correlates with the absence of progenitor
markers in the hindgut of mutant animals at early develop-
mental stages.
Strikingly, although they were not completely absent as in the
hindgut, progenitor cells were reduced in number in the
duodenum and in the midgut of five out of five mutant
embryos. While normally the developing myenteric plexus of
the proximal gut is outlined by multiple progenitor cells
forming a continuous ring of Sox10 expression (arrow in
Fig. 2C), Sox10-positive cells appeared sparsely distributed in
the early ENS of the mutant midgut (open arrow in Fig. 2D).
Likewise, higher magnification of proximal gut sections
hybridized with an ErbB3 riboprobe revealed that ErbB3
staining was confined to relatively few ENS progenitor cells in
the mutant midgut, while many ErbB3-positive cells were
detectable on wild-type sections (arrows in Fig. 2E and F).
The apparent reduction of progenitor cells in the midgut and
hindgut of Sox10-mutant embryos could have two alternative
explanations. Enteric progenitor cells might be generated in
normal numbers in the mutant, but these cells might for some
reason be unable to properly colonize the gut in a proximal to
distal direction. Alternatively, the total number of enteric
progenitors in the intestine might be decreased and failure to
Figure 2. The hindgut of Sox10lacZ/þ mutants is not colonized by enteric progenitor cells and the number of progenitors in more proximal parts of the gut is
reduced. In situ hybridization studies showed readily detectable Sox10 expression levels in dorsal root ganglia (DRG) and peripheral nerve of wild-type (þ/þ)
and mutant (þ/) embryos at E13 (A, B). nt, neural tube. In contrast, the hindgut (HG) of Sox10lacZ/þ animals at E13 is devoid of Sox10 expression (D; open
arrowhead). At this developmental stage, the wild-type hindgut is colonized by Sox10-positive cells (C; arrowhead). At the level of duodenum and midgut (MG),
the expression levels of the progenitor markers Sox10 and ErbB3 are reduced in the mutant (open arrows in D, F) as compared with the wild-type (arrows in C, E).
Note the unaltered expression levels of ErbB3 in the mutant gut epithelium (GE) (compare E and F). Scale bars: (B, D) 200 mm; (F) 100mm.
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populate distal gut regions might primarily be due to a loss of
progenitors. To address this issue, we quantified the total
number of enteric progenitor cells present in whole intestine of
wild-type or mutant embryos at different developmental stages.
Apart from Sox10 and ErbB3, migratory and postmigratory
neural crest stem cells are marked by the low-affinity
neurotrophin receptor p75 (28–30) and multipotent enteric
progenitors have previously been isolated by virtue of their p75
expression (31,32). Likewise, in Sox10lacZ/þ animals, p75
expression marks undifferentiated neural crest cells in neural
crest explants, dissociated DRG and gut (Fig. 3A–F) (24).
Moreover, all undifferentiated mutant neural crest cells
prepared from various neural crest targets, including the gut,
can also be characterized by Sox10 protein expression
(Fig. 3A–F) (24). Therefore, for a quantification of enteric
progenitor cells, we dissociated the intestine of wild-type and
mutant embryos at different developmental stages, plated the
cells onto culture dishes and, 3 h after plating, determined by
immunocytochemistry the fraction of cells that were positive
for both p75 and Sox10. To account for possible variability in
penetrance of the phenotype, whole intestines from three
different embryos per stage were analysed. Counting 1000
cells per embryo at E13 demonstrated that 4.8% of all cells
were p75/Sox10-positive multipotent progenitor cells in the
wild-type (Fig. 3G). This number was only 3.2% in the Sox10
mutant, equivalent to a reduction of 33%. At later stages, the
loss of enteric progenitors was even more pronounced. At E15,
8.8% of all cells displayed features of progenitor cells in the
wild type. In the mutant at E15, however, only 5.2% of all cells
were progenitors, corresponding to a reduction of progenitor
numbers of 41% (Fig. 3G). Furthermore, at E17, the number of
p75/Sox10-positive cells present in whole intestine of Sox10-
mutant embryos was decreased by 50% (from 6.9% of all cells
in the wild type to 3.5% in the mutant; Fig. 3G). Thus, these
data confirm the results of our in vivo experiments (Fig. 2) and
demonstrate that Sox10 haploinsufficieny leads to a reduced
size of the multipotent progenitor pool in the gut.
Sox10 haploinsufficiency does not affect
survival of enteric progenitors
In Sox10Dom-homozygous mutant embryos, neural crest
cells fail to colonize the gut and instead undergo massive
cell death (22). Similarly, the analysis of Sox10lacZ/lacZ
embryos revealed a requirement of Sox10 for survival of
neural crest cells (24) and, consistently, enteric progenitors are
completely absent in the gut of Sox10lacZ/lacZ embryos (19).
Thus, the loss of enteric progenitors in Sox10lacZ/þ embryos
might be attributed to increased apoptosis of mutant cells. To
investigate this issue, we performed a TUNEL assay on gut
sections at various developmental stages. Comparison of wild-
type and Sox10-heterozygous mutant embryos at E11, E12,
E13 and E15 revealed generally low numbers of apoptotic
figures in the embryonic gut and did not indicate any
increased cell death of enteric cells in mutant intestine (Fig. 4;
and data not shown). These data are consistent with our
previous finding, that Sox10 homozygous but not hetero-
zygous mutation affects survival of cultured multipotent trunk
neural crest cells (24). Cell death, therefore, cannot be
responsible for the reduced amount of enteric progenitor cells
found in Sox10-heterozygous mutants.
Enteric neural crest-derived cells lose their
progenitor state and acquire preneuronal
traits in Sox10-heterozygous mutant animals
Cell culture experiments had allowed us to demonstrate that,
dependent on the extracellular context, Sox10lacZ/þ trunk
neural crest cells adopt fates different from those chosen by
their wild-type counterparts (24). Accordingly, the phenotype
in the ENS of Sox10-heterozygous mutant animals might also
be explained by aberrant cell fate decisions. In the Sox10-
mutant mice we used, the complete open reading frame of
Sox10 has been replaced by lacZ gene sequences (19).
Therefore, Sox10 promoter activity can be monitored in
Sox10lacZ mice by measuring b-galactosidase activity.
Thereby, the persistence of this enzyme in enteric neural
crest derivatives not only allows detection of cells that express
Sox10 but also in vivo fate mapping of cells in which the
Sox10 promoter has been active at earlier stages. To follow
the fate of mutant cells, we performed b-galactosidase
stainings on sections of Sox10lacZ/þ embryos at E13 and
E15. In parallel, in situ hybridization experiments using a
Sox10 riboprobe were carried out on adjacent sections of
mutant embryos and on wild-type sections displaying gut
segments comparable to the mutant. As mentioned above, the
mutant hindgut lacked Sox10-positive cells at E13 while
Sox10 expression was found in the wild-type hindgut.
Likewise, b-galactosidase activity was undetectable in the
hindgut of Sox10-heterozygous mutants at E13 (Fig. 5C,
inset). Given the absence of cell death at all stages examined
(Fig. 4; and data not shown), our data suggest that neither
Sox10-expressing progenitor cells nor their derivatives were
able to properly colonize the hindgut.
In the midgut, Sox10 expression in mutant embryos was
reduced at E13 as compared to the wild-type (Fig. 5A and B;
see also Fig. 2). This reduction was even more obvious at E15,
when in some areas of the mutant midgut Sox10 expression
was below detection limits while robust expression was found
in similar areas of wild-type embryos (Fig. 5D and E).
Strikingly, both at E13 and E15, large numbers of cells in the
enteric plexus of Sox10lacZ/þ mutant midgut displayed b-
galactosidase activity even in regions in which Sox10 was not
or was barely detectable on adjacent sections (Fig. 5B, C, E and
F). b-galactosidase activity persisted at least up to E17, the
latest stage examined (Fig. 6I; and data not shown). Thus,
descendents of Sox10-expressing cells had localized in high
numbers to midgut portions of Sox10-heterozygous embryos
but, unlike many of their wild-type counterparts, down-
regulated expression of the progenitor state marker Sox10.
This finding was supported by the quantitative analysis of
b-galactosidase-positive cells obtained by dissociating whole
intestine of mutant embryos. While at E17 only 3.5% of all
cells were marked by Sox10 immunostaining (Fig. 3G), 11%
of all cells displayed b-galactosidase activity, indicating that
most neural crest-derived cells in the mutant had lost Sox10
protein expression.
The failure of neural crest-derived cells to maintain their
progenitor state raises the question of what fate these cells
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adopt instead. Previously we have demonstrated that aberrant
fate decisions by Sox10-heterozygous mutant trunk neural crest
cells are context-dependent (24). In particular, when cell–cell
interactions are allowed to occur in the absence of instructive
gliogenic growth factors, these mutant cells are biased to
generate neuronal cells. Alternatively, mutant cells might adopt
a non-neuronal fate. During ENS development, the tyrosine
kinase receptor c-Ret is first expressed by postmigratory enteric
progenitor cells derived from p75/Sox10/ErbB3-positive neural
crest cells and is later confined to the neuronal lineage (33,34).
In vitro, Sox10 regulates the expression of c-ret in synergy with
the transcription factor Pax3 (35) and mutations in Sox10 might
thus prevent expression of c-ret and other preneuronal traits. To
determine the nature of the enteric cells derived from mutant
progenitor cells, we performed double labeling experiments,
staining midgut sections of E15 embryos for b-galactosidase
and early neuronal markers. Confocal microscopy analysis of
midgut sections at E15 revealed that virtually all mutant neural
crest-derived cells expressing b-galactosidase also expressed
c-Ret (Fig. 6A–C). The neuron-specific protein PGP9.5 is
expressed in enteric preneuronal and neuronal cells that have
downregulated Sox10 protein expression (25,36,37). Strikingly,
Figure 3. Reduction of the ENS progenitor pool in Sox10lacZ/þ mutants. The intestine of wild-type and mutant animals was dissected, dissociated and plated onto
cell culture dishes. The cells were immunolabeled for both p75 (visualized by a Cy3-coupled secondary antibody) (A, D) and Sox10 (visualized by FITC) (B, E).
(C) and (F) show corresponding phase pictures. (G) The fraction of cells that were progenitors was determined by anti-p75/anti-Sox10 double immunocytochem-
istry. The numbers represent mean values from three independent animals, counting 1000 cells each. Sox10lacZ/þ mutants showed a significantly reduced pro-
genitor pool at stages E13, E15 and E17. A Student’s t-test revealed significant differences between control and mutant animals: E13, P< 0.003; E15, E17,
P< 0.0001.
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the vast majority of b-galactosidase-positive cells found in
Sox10lacZ/þ mutant midgut coexpressed PGP9.5 (Fig. 6D–F).
In contrast, cells expressing late neuronal differentiation
markers such as neurofilament 160 and peripherin were
detectable much less frequently than b-galactosidase-
expressing cells, both at E15 and E17 (Fig. 6G–I; and data
not shown). Thus, without leading to precocious appearance of
fully differentiated neurons, Sox10 haploinsufficiency promotes
loss of the progenitor state and preferential acquisition of
neuronal precursor characteristics by mutant neural crest cells
in the gut.
DISCUSSION
Mutations in Sox10 have been associated with enteric
aganglionosis both in mice as well as in human patients
with Hirschsprung disease (1,38). However, the molecular
and cellular basis underlying the etiology of this disease has
been elusive. In this study, we present evidence that aberrant
fate decisions by enteric progenitor cells very early in
development result in the absence of enteric ganglia in the
distal gut of afflicted individuals (Fig. 7). In wild-type
embryos, vagal neural crest cells, the major source of the
ENS, migrate into proximal portions of the gut to gradually
colonize its entire length (1). Although neurogenesis is
observed at early developmental stages, progenitor cells with
migratory capacity are maintained during prolonged periods
of development (32). In a mouse model of Hirschsprung
disease, Sox10-heterozygous mutant neural crest cells are
able to migrate into proximal portions of the intestine during
early embryonic development. However, in contrast to wild-
type cells, mutant cells progressively lose their progenitor
state and instead adopt traits of neuronal precursors. This
results in a depletion of the overall progenitor pool. As a
consequence, the hindgut in the mutant cannot be colonized
by progenitor cells, leading to aganglionosis of the terminal
bowel.
Context-dependent fate decisions by
Sox10-mutant neural crest cells
Previously, it has been shown that most neural crest derivatives
are defective in mice homozygous for the Dom mutation or for
a targeted deletion of Sox10 (17–19). In particular, the entire
ENS is missing in these mutants, as neural crest cells
completely fail to colonize the gut. This phenotype was
explained by death of neural crest cells at early stages of neural
crest development (22). Accordingly, multipotent trunk
neural crest cells isolated from Sox10lacZ/lacZ mice display
decreased survival capacity, revealing a cell-autonomous role
of Sox10 in survival (24). The question was raised, therefore,
whether aganglionosis in the distal gut of Sox10-heterozygous
mutants might also be due to increased death of neural crest
cells (39). However, the survival function of Sox10 can
apparently be elicited by Sox10-protein levels present in
heterozygous mutant cells, since cultured Sox10-heterozygous
mutant neural crest cells, unlike homozygous mutant cells,
survive as well as wild-type neural crest cells (24). In
accordance with this finding, cell death was not increased in
the developing ENS of Sox10lacZ/þ animals, as assayed by
TUNEL at several developmental stages.
Analysis of the developmental potential of wild-type and
mutant trunk neural crest cells revealed, however, a second
function of Sox10 in multipotent neural crest cells. Under
certain conditions, mutant cells tend to acquire aberrant fates as
compared with wild-type cells, depending on the presence or
absence of instructive growth factors and on short-range cell–
cell interactions (24). These findings demonstrate that changing
Sox10 levels in multipotent neural crest cells alters their
responsiveness to the multiple cues present in the extracellular
environment. In the developing embryo, migratory and
postmigratory mutant neural crest cells are obviously exposed
to different environmental contexts that change with the
localization of the cell and the developmental stage. In
the context of the developing gut, mutant progenitor cells are
apparently unable to properly respond to their environment and
to efficiently generate all ‘fates’ appropriate for early ENS
development, namely maintenance of a progenitor state and
adoption of a neuronal fate. This is best shown by in vivo fate
mapping of Sox10-heterozygous mutant cells that express
b-galactosidase from the Sox10 locus. The extent of
b-galactosidase activity in proximal segments of the mutant
gut is comparable to the expression domain of neural markers
in the wild type, confirming our above-mentioned data that the
progeny of Sox10-expressing neural crest cells are not
eliminated by cell death. However, most b-galactosidase-
positive neural crest-derived cells fail to express the progenitor
markers Sox10 and ErbB3 and the total number of undiffer-
entiated enteric progenitor cells is substantially decreased in the
mutant relative to the wild-type gut. Instead, we observed
expression of early neuronal markers in the vast majority of
mutant cells in the midgut. It is worth mentioning, though, that
the total number of differentiated neurons in this area seems not
to be altered as compared with wild-type embryos, indicating
that neuronal cell numbers are regulated by secondary,
Figure 4. Sox10 haploinsufficiency does not affect survival of ENS cells.
TUNEL assays on gut sections at developmental stages E11 and E13 did not
indicate any increased cell death in the gut of heterozygous (B, D; arrows) as
compared with wild-type (A, C; arrows) sections. The arrowhead in (A) indi-
cates apoptotic cells in areas outside of the gut. Scale bars: (B) 200mm; (D)
400mm.
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Sox10-independent mechanisms. In conclusion, we have shown
that Sox10 in neural crest cells is crucial for the maintenance of
the progenitor state in the developing ENS. The behavior of
isolated Sox10-mutant neural crest cells in culture and the fact
that mutant gut is permissive to colonization by wild-type ENS
progenitors indicates that this function of Sox10 in ENS
progenitors is cell-autonomous (22,24).
Sox10-mutant mice as a model system for
Hirschsprung disease
Our finding that the enteric progenitor pool is not maintained in
Sox10-mutant embryos raises the question of how this leads to
the observed aganglionosis in the hindgut. It has been proposed
that the migratory ability of enteric crest-derived cells decreases
with their progressive differentiation, with neuroblasts and
neurons being more sessile than undifferentiated progenitor
cells (40). Accordingly, the generation of neuronal cells with the
concomitant loss of the progenitor state in Sox10-heterozygous
neural crest cells would result in a depletion of cells with
migratory potential. Alternatively, the depletion of progenitor
cells might simply lead to a decrease in total cell numbers of the
mutant ENS. In both cases, the hindgut becomes aganglionic
because it is the last part of the gut to be colonized by neural
crest-derived cells (41). PGP9.5 and c-Ret, which we show to be
preferentially expressed by Sox10-heterozygous mutant cells,
are detectable at early stages of normal ENS development and
are not only marking committed or even differentiated neuronal
cells (33,36,37,42). Although the migratory capacity of c-Ret/
PGP9.5-positive cells has not been directly compared with that
of p75/Sox10-double positive and c-Ret-negative ENS-derived
neural crest cells, c-Ret-positive cells are able to colonize both
wild-type and aganglionic gut (42). This might suggest that it is
not a decreased migratory capacity of mutant cells per se that
would result in an aganglionic terminal bowel in Hirschsprung
disease. However, the developmental potential of c-Ret-
expressing cells appears to be more restricted than the potential
of p75-positive/c-Ret-negative neural crest cells, with some
c-Ret-positive cells being already committed to a neuronal
fate (33). Most importantly, c-Ret-positive ENS cells display a
decreased proliferative capacity as compared with p75-positive/
c-Ret-negative neural crest cells (33). This is true even for
uncommitted c-Ret-positive cells that quickly segregate into
neuronal and non-neuronal lineages. Based on this we propose
(Fig. 7) that by generating c-Ret-positive cells at the expense of
c-Ret-negative neural crest-derived progenitor cells, the pro-
liferation rate of ENS cells is reduced in Sox10-heterozygous
mutants. The decreased progenitor pool size described in this
study can thus not be compensated by the cells aberrantly
generated in the mutant, preventing efficient colonization of
distal gut segments by neural crest-derived cells.
In the wild-type, two sources of neural crest cells contribute
to colonization of the terminal bowel, vagal and sacral neural
crest (1). Vagal neural crest gives rise to ENS cells along the
entire length of the gut, whereas sacral neural crest cells only
colonize hindgut portions. The virtually complete absence of
neural crest-derived cells in Sox10-mutant hindgut at E13 as
assayed by Sox10-, ErbB3-, b-galactosidase- and neuronal
marker expression suggests that, apart from vagal neural crest
cells, sacral cells are also affected by the Sox10 mutation.
Figure 5. In vivo fate mapping of mutant ENS progenitor cells. In situ hybridization analysis on E13 and E15 midgut sections shows strong Sox10 staining in the
wildtype (A, D; arrows). In contrast, at E13 Sox10 mRNA expression is barely detectable in the heterozygous midgut (B; open arrow) and completely gone at E15
(E; open arrow). Note the readily detectable Sox10 expression in more proximal regions of the mutant gut (E, arrowhead). (C, F) In the mutant, b-galactosidase is
expressed from the Sox10-locus. Persistence of enzyme activity allows fate mapping of mutant progenitor cells. Adjacent sections to (B) and (E) were stained for
b-galactosidase activity and revealed prominent staining in the midgut at E13 (C; arrow) whereas the hindgut was devoid of b-galactosidase staining (inset in C). At
E15, b-galactosidase staining was still present at sites (F; arrow) where Sox10 mRNA was not detectable (E, open arrow), indicating that cells derived from pro-
genitors have survived but downregulated Sox10 expression. Scale bars: (C) 200mm; inset in (C) 100mm; (F) 400mm.
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The phenotype described in this study can, however, not be
explained solely by a failure in sacral neural crest cell
development, as progenitors in the midgut (which are derived
from vagal crest) are evidently affected. Moreover, it has been
shown that sacral neural crest cells only form a minority of the
postumbilical ENS that cannot compensate for missing vagal
crest-derived cells (41,43,44). Thus, we propose that the loss of
vagal crest-derived progenitor cells that is apparent in relatively
proximal parts of the gut is the main cause for the absence of an
ENS in more distal gut segments (Fig. 7).
Depletion of the enteric progenitor pool might also be the
cellular basis underlying Hirschsprung disease in patients
with mutations in genes of the ET-3/ETB signal transduction
pathway (8). Signaling by ET-3/ETB has an inhibitory effect
on the differentiation of enteric neurons (36,45). Therefore,
deficiencies in ET-3/ETB-signaling are thought to lead to
premature neuronal differentiation and, as a consequence, to
affect the progenitor pool size. Unlike in Sox10-mutants,
however, the resulting aganglionosis in the terminal bowel of
ET-3/ETB mutants cannot be explained solely by a neural crest
cell-autonomous effect, since an abnormal gut environment
contributes to the enteric phenotype in mice deficient in ET-3/
ETB-signaling (40). Mutations in RET and in genes encoding the
growth factors GDNF and NTN that signal through c-Ret also
lead to Hirschsprung disease (3). Although it has been suggested
that some mutations cause c-Ret to constitutively induce
apoptosis (46), the cellular mechanisms leading to aganglionosis
in the terminal bowel of patients with GDNF/NTN/RET
mutations is unclear. Mouse models demonstrate a crucial role
of GDNF/NTN/c-ret in ENS development but, unlike
Figure 6. b-Galactosidase-positive cells acquire early neuronal traits in the Sox10lacZ/þ mutant ENS. Confocal microscopy analysis of midgut sections at E15
revealed that many cells that are c-Ret positive as assessed by fluorescence in situ hybridization (A) are also positive for anti-b-galactosidase immunostaining
(B). Moreover, the anti-b-galactosidase staining (E) co-localizes with the neuronal marker PGP9.5 in many cells (D). (C) and (F) represent the corresponding
confocal overlays; the yellow color indicates double-positive cells. Single confocal planes are shown. In situ hybridization on E17 gut sections revealed relatively
few NF-positive differentiated neurons in the wild type (G) and the mutant (H). The domain of b-galactosidase staining on mutant midgut sections (I; arrow) is
broader than the NF-expression pattern (H; open arrow). The section shown in (I) is adjacent to the section displayed in (H). Scale bars: (C, F) 20mm; (I) 40mm.
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heterozygously-affected human patients, only display a pheno-
type as homozygotes in which not only the distal gut but the
entire intestine is affected (3,4). Nonetheless, given the
mitogenic activity of GDNF on neural crest-derived enteric
progenitors and the massive cell death of ENS progenitors in c-
ret-null mice, it is conceivable that aganglionosis in patients with
GDNF/NTN/RET mutations results from decreased proliferation
of progenitors or increased cell death or both of these (31,45,47).
In human patients, none of the mutations discussed above are
fully penetrant, identifying Hirschsprung disease as a multi-
factorial disorder (1,48). Interactions between different genetic
loci, including modulation of an ETB-dependent phenotype by
RET variants, have been reported. Variability in penetrance and
disease phenotype has also pointed to the existence of SOX10-
dependent modifier genes (20,21). To further elucidate the
etiology of Hirschsprung disease, it will be important to
identify these modifier genes (48) and to investigate the cellular
consequences of their interactions with known Hirschsprung
disease genes. The mouse mutant used in the present study is
an ideal model system to address such issues, given that, as in
human patients, mutations in Sox10 are haploinsufficient and
pleiotropic in mice. With this system it should be feasible to
determine the molecular mechanisms by which Sox10 regulates
maintenance of ENS progenitors and how this process might be
modulated by other factors.
MATERIALS AND METHODS
Sox10lacZ mice
Sox10-mutant mice were maintained in a C3HeB/FeJ back-
ground (19). All experiments were performed analysing the F1
generation by crossing mutant mice with C57/Bl6 mice. Tissue
from a forelimb was used for genotyping by PCR (19).
Cell cultures
Cell culture preparations of dissociated gut were done as
follows: at E13, the entire gut distal to the stomach was
Figure 7. Cellular basis for Hirschsprung disease in Sox10lacZ/þ animals. During normal enteric development, p75þ/Sox10þ/ErbB3þ vagal neural crest cells
migrate into the proximal part of the gut and gradually colonize the entire length of the gut to give rise to differentiating neuroblasts (NB) that express the neuronal
precursor markers c-Ret and PGP9.5. In Sox10lacZ/þ mutants, maintenance of the progenitor state is impaired (illustrated by thinner arrows) and, therefore, the
number of progenitor cells produced in the gut is reduced. Cells expressing c-Ret and PGP9.5 are generated at the expense of p75þ/Sox10þ/ErbB3þ neural
crest-derived progenitor cells. These preneuronal cells can be detected by virtue of the b-galactosidase activity persisting in neural crest-derived cells. They have
a reduced proliferative capacity (33) and can therefore not compensate for the loss of undifferentiated neural crest-derived progenitors in the mutant. As a con-
sequence, cells with migratory capacity are not present in high enough numbers to colonize more distal parts of the gut. The absence of progenitor cells in the
hindgut ultimately leads to aganglionosis of the terminal bowel.
Human Molecular Genetics, 2002, Vol. 11, No. 24 3083
dissected and digested in 1 mg/ml collagenase type I
(Worthington Biochemical, NJ, USA) in Ca2þ/Mg2þ-free
Hank’s balanced salt solution (Amimed) for 20 min at 37C.
Preparations from E15 and E17 were digested for 45 min in a
solution that, in addition to the collagenase, contained 0.01%
trypsin (Gibco BRL). The digestion was stopped by the
addition of 10% fetal bovine serum (FBS). Subsequently, the
cells were centrifuged for 2 min at 680 g, triturated, and plated
onto dishes coated with 0.25 mg/ml fibronectin (Roche
Diagnostics). Four hours after plating in standard medium
(24), the cells were fixed with 3.7% formaldehyde (FA) in
phosphate-buffered saline (PBS) for 10 min and analysed.
Immuno- and b-galactosidase staining reactions
For immunocytochemistry, the cells were permeabilized and
blocked for 10 min at room temperature (RT) with blocking
buffer (10% goat serum, 0.3% Triton X-100, 0.1% BSA in
PBS). Progenitor cells were labeled with rabbit anti-mouse p75
(Chemicon International) diluted 1 : 200 in blocking buffer for
1 h at RT and with a monoclonal anti-Sox10 antibody (1 : 3
dilution) (24) for 2 h at RT. Immunostaining on cryosections
was performed with rabbit anti-b-galactosidase (ICN/Kappel)
diluted 1 : 100 in blocking buffer for 2 h at RT and monoclonal
anti-human PGP9.5 (UltraClone) diluted 1 : 40 for 3 h at RT.
All immunostainings were visualized by incubation for 1 h at
RT using the following reagents at a 1 : 200 dilution: Cy3-
conjugated goat anti-rabbit IgG and goat anti-mouse IgG
(Jackson Immuno Research Laboratories); and FITC-conjugated
horse anti-mouse IgG (Vector Laboratories). For X-Gal staining
on cryosections, the sections were fixed for 10 min in 2% FA at
RT, washed twice in PBS and stained for 2 h at 37C in staining
solution (1 mg/ml X-Gal, 5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6;
2 mM MgCl2 in PBS).
TUNEL assay
Cryosections were fixed in 2% PFA/PBS for 10 min, washed
three times for 5 min in PBS and blocked for 1 h in 10% goat
serum, 0.1% BSA, 1% Triton X-100 in PBS. The TUNEL
staining was performed according to the manufacturer’s
instructions (Roche Diagnostics) and visualized by
Cy3-conjugated streptavidin (1 : 200 dilution, Jackson
ImmunoResearch Laboratories). Finally, the sections were
mounted in AF1 (Citifluor).
Non-radioactive in situ hybridization
Non-radioactive in situ hybridization with digoxigenin-labeled
riboprobes was performed on frozen sections of paraformalde-
hyde-fixed mouse embryos as described in (49). NBT/BCIP
were used as chromogens to visualize the hybridization signals.
The c-Ret fluorescent in situ hybridization combined with anti-
b-galactosidase immunostaining was done as reported in (49)
using the tyramide signal amplification method (Perkin Elmer).
After washing in PBS, the sections were mounted in AF1
(Citifluor) and analysed by confocal microscopy.
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